Beijing Haiyan Pharmaceutical wins the market with its products, not only has Suhuang cough capsule entered the 2020 edition of Chinese Pharmacopoeia, but also ARB Cosu (Irbesartan tablet) recommended by many well-known experts. This fully shows that the company seized the opportunity of pharmaceutical industry change, with innovative research and development and high-quality development of the two-wheel drive, to achieve high-speed and healthy development of enterprises; Bold industrial extension and integration, committed to the health field, to become a worthy of trust, the ideal of the domestic first-class enterprises.

Recently, the list of "Excellent Enterprises and Excellent Product Brands in China's Chemical and Pharmaceutical Industry in 2020" was announced. The list is jointly organized and recommended by China Chemical and Pharmaceutical Industry Association, China Pharmaceutical Business Association, China Over-the-counter Drug Association, China Vaccine Industry Association and Reed Sinoptila Exhibition Co., LTD., with a total of 29 awards in four sectors. Many well-known pharmaceutical companies with good performance, brand competitiveness and outstanding performance in new drug research and development innovation are listed.

Beijing Haiyan Pharmaceutical Co., Ltd. won three awards of "Top 100 Industrial Enterprises in China's Chemical and Pharmaceutical Industry with Comprehensive Strength in 2020, Excellent Brand of Blood Pressure Lowering Products in China's Chemical and pharmaceutical Industry, and Excellent Enterprise Products promoted by the integration of the two chemical and pharmaceutical industries in China", becoming the "winner" of the annual list.

The three awards won this time are not only the recognition of the brand strength of Beijing Haiyan Pharmaceutical from all walks of life, but also the best proof of the excellent quality of the products and the solid R & D and innovation ability of the enterprise.